Locations:
Search IconSearch
January 2, 2024/Neurosciences/Podcast

Harnessing the Power of Neuroengineering and AI to Improve Epilepsy Surgery (Podcast)

Data-driven methods may improve seizure localization and refine surgical decision-making

Approximately one-third of people with epilepsy have seizures refractory to medications. For those patients, surgery offers the best chance for decreased seizure burden and perhaps seizure freedom. However, no more than 1% to 2% of North American patients who would benefit from surgery are referred to a surgeon’s office.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Demitre Serletis, MD, PhD, an associate professor and neurosurgeon in Cleveland Clinic’s Epilepsy Center, is working to create a data-driven process — merging concepts from neuroengineering, artificial intelligence (AI) and machine learning — to improve care and outcomes for these types of patients.

“This is the era of brain exploration,” says Dr. Serletis, who is also a researcher with the Department of Biomedical Engineering in Cleveland Clinic Lerner Research Institute. “We open the skull, we resect some of the brain tissue there and we sometimes place devices — all in a very coordinated, methodical way. We must now curate and learn from this experience. That will allow us to shape future directions in an informed fashion.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Serletis discusses his research and the future of epilepsy surgery and treatment. He covers:

  • Current surgical modalities, including resection, ablation and implantable devices
  • The efficacy of contemporary epilepsy surgery, including opportunities and challenges
  • Application of neuroengineering and machine learning to study intracranial recordings of seizure activity from the brain
  • The potential for AI to predict who may benefit from epilepsy surgery and to help personalize decision-making

Click the podcast player above to listen to the 30-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Advertisement

This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Dr. Serletis: We’d like to learn a bit more about the dynamical principles that lead to seizure start and spread. Can we predict it? As surgeons, we put 15 or 20 electrodes in the brain. There is risk with every single pass, and we’re never sure that we’re going to be right in the exact spot. So, can we extrapolate to better refine the analysis?

Ultimately, this will allow us to build a dynamical platform where we are no longer reviewing just clinical data but also the mathematical and dynamical aspects of this, to enable characterization of patients into profiles that allow us to predict who will benefit from what therapy. At the same time, this will also provide a better way to inform industry on how to design devices to best stimulate the brain.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad